1. Home
  2. ICCC vs AEYE Comparison

ICCC vs AEYE Comparison

Compare ICCC & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$11.11

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

AEYE

AudioEye Inc.

HOLD

Current Price

$5.81

Market Cap

83.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
AEYE
Founded
1982
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
83.6M
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
ICCC
AEYE
Price
$11.11
$5.81
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$14.63
AVG Volume (30 Days)
23.8K
59.5K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
30.56
EPS
0.21
N/A
Revenue
$26,493,169.00
$40,311,000.00
Revenue This Year
N/A
$11.12
Revenue Next Year
N/A
$11.45
P/E Ratio
$51.19
N/A
Revenue Growth
51.64
14.52
52 Week Low
$4.52
$5.31
52 Week High
$12.10
$16.39

Technical Indicators

Market Signals
Indicator
ICCC
AEYE
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
ICCC
AEYE

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences. It generates revenue through the sale of subscriptions for software-as-a-service (SaaS). accessibility solutions.

Share on Social Networks: